Summary
CVS Health Corporation (CVS) has filed a Form 8-K on May 6, 2026, to report its financial results for the three months ended March 31, 2026. The key details of these results are provided in a press release, furnished as Exhibit 99.1 to this filing. This filing is primarily an informational update, alerting investors to the company's performance during the first quarter of 2026. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release for a comprehensive overview. Investors should review Exhibit 99.1 to understand the company's revenue, earnings, and any significant operational developments or guidance provided for the period. It's important to note that the information furnished in this 8-K is not considered "filed" for certain regulatory purposes, meaning it won't be automatically incorporated into other SEC filings unless explicitly referenced.
Key Highlights
- 1CVS Health announced Q1 2026 financial results via a press release filed on May 6, 2026.
- 2The 8-K filing serves to furnish the press release containing the quarterly results.
- 3Investors need to refer to Exhibit 99.1 (the press release) for detailed financial performance data for the period ended March 31, 2026.
- 4The filing incorporates the press release by reference under Item 2.02 (Results of Operations and Financial Condition).
- 5Information furnished in this 8-K is not deemed "filed" under Section 18 of the Exchange Act.
- 6The report includes the Cover Page Interactive Data File (XBRL) as Exhibit 104.